Plantar fasciosis Musculoskeletal Diseases
Conditions
Interventions
The groups will be randomly assigned, and each group will be assigned to a specific infiltration site:
1. Group 1 (perilesional infiltration): Patients will be treated with perilesional dextrose infil
Sponsors
Universidad Complutense de Madrid
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged between 30 and 65 years 2. Present symptoms compatible with plantar fasciitis of at least 30 days of evolution 3. Presence of ultrasound thickness greater than 0.4 cm 4. Signing of informed consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Suffering from systemic diseases or morphofunctional alterations unrelated to the foot that could affect the ankle and foot, potentially leading to significant clinical discrepancies in the lower limbs, asymmetries or evident clinical scoliosis 2. Having received any treatment (medical, orthopedic and/or invasive) for the foot in the last 3 months 3. Suffering from plantar pain associated with another condition, such as autoimmune disease or nerve entrapment 4. Difficulties in understanding the instructions necessary during treatment
Countries
Spain
Contacts
Public ContactÁlvaro Saura
Outcome results
None listed